Pharmaceutical Grade Sodium Chloride Market by Applications 2025 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Pharmaceutical Grade Sodium Chloride Market
Pharmaceutical Grade Sodium Chloride Market: By Applications (injections, oral rehydration salt (ORS), hemodialysis, peritoneal dialysis & hemofiltration solutions, channeling agents/ osmotic agent, mechanical cleansing solutions, dietary formulations and infant formulations) & By Region - Forecast (2017- 2022)
Report Code : CMR 0626
Published: 08 March, 2017  

  • Report Description
  • Table of Contents
  • Customization Options
Pharmaceutical grade sodium chloride or pharmaceutical salt is a screened, granular, white crystalline sodium chloride manufactured under stringent process control procedures. This form of sodium chloride is mainly used in peritoneal dialysis, mechanical cleansing solutions, ORS and others. North America is expected to have the largest market for pharmaceutical grade sodium chloride. Globally increasing cases of chronic diseases is expected to remain key growth driver for pharmaceutical industry during the period of study.

This report identifies the pharmaceutical grade sodium chloride market size in for the year 2015-2017, and forecast of the same for year 2022. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects with respect to global pharmaceutical grade sodium chloride market.

Pharmaceutical Grade Sodium Chloride Market

Geographically North America dominated the pharmaceutical grade sodium chloride market owing to presence of large number of pharmaceutical industry players and higher demand from the well-developed healthcare industry in the region. North America was followed by Asia-Pacific and Europe as the second and third largest markets for pharmaceutical grade sodium chloride. However Asia-Pacific is expected to remain the fastest growing market during the period of study driven by rapidly expanding pharmaceutical industrial base and rapidly growing healthcare sector and medical tourism in the region as a result of low cost for treatments as compared to developed nations. 

This report segments pharmaceutical grade sodium chloride market on the basis of applications and regional market as follows:
  • On the basis of applications this report on pharmaceutical grade sodium chloride market is segmented as follows, covering all major applications in the pharmaceutical grade sodium chloride as follows: injections, oral rehydration salt (ORS), hemodialysis, peritoneal dialysis, & hemofiltration solutions, channeling agents/ osmotic agent, mechanical cleansing solutions, dietary formulations and infant formulations
  • This report on pharmaceutical grade sodium chloride has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region

Sample Companies Profiled in this Report are:
  • Salinen Austria AG 
  • Sudsalz Gmbh 
  • Cheetham Salt Ltd. 
  • Swiss Saltworks AG 
  • US Salt LLC
  • 30+.
1. Pharmaceutical Grade Sodium Chloride Market – Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Pharmaceutical Grade Sodium Chloride Market– Forces
   4.1. Drivers
      4.1.1. Rapidly growing cases of chronic disease
      4.1.2. Strong Demand for Pharmaceutical Grade Sodium Chloride in North America and Europe
   4.2. Restraints
      4.2.1. Stringent regulations for pharmaceutical industry in major regions
   4.3. Opportunities
      4.3.1. Pure and Certified Pharmaceutical Salt
      4.3.2. Increased Spending Power in Emerging Markets
   4.4. Challenges
      4.4.1. Developing new products and technologies
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Pharmaceutical Grade Sodium Chloride Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life cycle Analysis
   5.5. Suppliers & Distributors
6. Pharmaceutical Grade Sodium Chloride Market, By Applications
   6.1. Injections
   6.2. oral rehydration salt (ORS)
   6.3. hemodialysis
   6.4. peritoneal dialysis & hemofiltration solutions
   6.5. channeling agents/ osmotic agent
   6.6. mechanical cleansing solutions
   6.7. dietary formulations and infant formulations
   6.8. Others
7. Pharmaceutical Grade Sodium Chloride Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Middle East
      7.4.2. South America
      7.4.3. Africa
8. Pharmaceutical Grade Sodium Chloride – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Akzonobel N.V. 
   9.2. K+S AG 
   9.3. Dominion Salt Ltd. 
   9.4. Cargill Incorporated 
   9.5. Tata Chemicals Limited 
   9.6. Salinen Austria AG 
   9.7. Sudsalz Gmbh 
   9.8. Cheetham Salt Ltd. 
   9.9. Swiss Saltworks AG 
   9.10. US Salt LLC 
   9.11. Hebei Huachen Pharmaceutical Co., Ltd 
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibiliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll